Biocon Biologics Achieves Major U.S. Market Access for Yesintek™, Strengthening India’s Global Biopharma Footprint
In a significant step for India’s biopharmaceutical innovation on the global stage, Biocon Biologics Ltd. (BBL), a subsidiary of Biocon […]
